Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Also Known As:

Anti-Arrhythmia Drugs; Anti-Arrhythmics; Antiarrhythmia Agents; Antiarrhythmia Drugs; Antiarrhythmic Drugs; Agent, Anti-Arrhythmia; Agent, Antiarrhythmia; Agent, Antifibrillatory; Agents, Anti-Arrhythmia; Agents, Antiarrhythmia; Agents, Antifibrillatory; Anti Arrhythmia Agent; Anti Arrhythmia Agents; Anti Arrhythmia Drug; Anti Arrhythmia Drugs; Anti Arrhythmic; Anti Arrhythmics; Depressant, Cardiac; Depressant, Myocardial; Depressants, Cardiac; Depressants, Myocardial; Drug, Anti-Arrhythmia; Drug, Antiarrhythmia; Drug, Antiarrhythmic; Drugs, Anti-Arrhythmia; Drugs, Antiarrhythmia; Drugs, Antiarrhythmic; Anti-Arrhythmia Agent; Anti-Arrhythmia Drug; Anti-Arrhythmic; Antiarrhythmia Agent; Antiarrhythmia Drug; Antiarrhythmic Drug; Antifibrillatory Agent; Antifibrillatory Agents; Cardiac Depressant; Cardiac Depressants; Myocardial Depressant; Myocardial Depressants

Chemical Actions and Uses
- Pharmacologic Actions: 160
  - Therapeutic Uses: 47080
    - Cardiovascular Agents: 817
      - Anti-Arrhythmia Agents: 5154

Joanna Szymot Selected Research

Joanna Szymot Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure